Clinical trial
Zyprexa® Relprevv™ Patient Care Program
NCT01088386 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Zyprexa® Relprevv™ Patient Care Program
- Lead sponsor
- Eli Lilly and Company
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- March 3, 2010
- Completion date
- June 30, 2026
- Enrollment
- 4,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.